[1]
“Efficacy and Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with DA-EPOCH-R Regimen: A Single-Centre Experience”, Sarawak J Pharm, vol. 8, no. 2, pp. 19–30, Dec. 2022, Accessed: Mar. 22, 2026. [Online]. Available: https://sjpharm.org/ojs/index.php/sjp/article/view/47